Black Diamond Therapeutics, Inc.
BDTXBiotechnology
$1.78−4.30%As of Oct 30vs prior close
- Market cap
- $102.3M
- P/E (TTM)
- 4.6×
- From 52W high
- −63.45%
- EPS (YE25)
- $0.39
- Revenue (YE25)
- $70M
- Net margin
- 31.95%
Nomior Score
44
Steady ProfileBottom 37% of the scored universe
Growth—
Quality71
Value61
Momentum10
Resilience44
Growth
$70Mrevenue, YE25
YE18 $0YE25 $70M
Connections
Revenue to profitQ1 YE25
81% of revenue became net profit.
Who owns it
2funds